BlueCrest Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14,967	Closed	-$1.49M	–	473
2019 Q3	$1.49M	Buy	14,967 +9,318	+165%	+$975K	0.1%	145
2019 Q2	$616K	Buy	+5,649	New	+$601K	0.04%	194
2019 Q1	–	Sell	-26,257	Closed	-$2.53M	–	1253
2018 Q4	$2.53M	Buy	26,257 +15,060	+135%	+$1.6M	0.13%	118
2018 Q3	$1.36M	Sell	11,197 -65,015	-85%	-$7.66M	0.04%	350
2018 Q2	$8.37M	Buy	76,212 +64,237	+536%	+$6.87M	0.22%	97
2018 Q1	$1.28M	Sell	11,975 -92,804	-89%	-$10.3M	0.04%	416
2017 Q4	$11.2M	Sell	104,779 -144,296	-58%	-$15.4M	0.3%	59
2017 Q3	$27.7M	Buy	249,075 +182,997	+277%	+$19.6M	1.13%	9
2017 Q2	$6.83M	Buy	+66,078	New	+$6.51M	0.26%	111
2017 Q1	–	Sell	-92,799	Closed	-$8.21M	–	848
2016 Q4	$8.21M	Buy	+92,799	New	+$8.45M	0.45%	53
2016 Q3	–	Sell	-59,388	Closed	-$5.09M	–	859
2016 Q2	$5.09M	Buy	+59,388	New	+$5.33M	0.21%	111
2015 Q4	–	Sell	-53,358	Closed	-$5.39M	–	1071
2015 Q3	$5.39M	Buy	+53,358	New	+$6.4M	0.18%	101